Literature DB >> 8711647

Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients.

K Shindo1, K Koide, Y Hirai, M Sumitomo, M Fukumura.   

Abstract

BACKGROUND: Eosinophils from asthmatic patients are known to release greater amounts of leukotrienes than normal eosinophils when stimulated by the calcium ionophore A23187. The effect of platelet activating factor (PAF) in priming eosinophils was investigated.
METHODS: Eosinophils were obtained from 18 asthmatic patients and 18 healthy donors. Cells separated by the Percoll gradients were incubated with PAF (C-18) for 30 minutes and then stimulated with the calcium ionophore A23187 (2.5 microM) for 15 minutes. The amount of leukotriene C4 (LTC4) in supernatants was measured using a combination of high pressure liquid chromatography and radioimmunoassay.
RESULTS: The mean (SD) amount of LTC4 released by eosinophils from asthmatic patients upon stimulation with the calcium ionophore A23187 alone was 27.9 (9.9) ng/10(6) cells (n = 6). The amount of LTC4 released following stimulation with the calcium ionophore A23187 after pretreatment with PAF (1, 5, and 10 microM) was 57.2 (8.9), 75.1 (14.3), and 52.6 (10.7) ng/10(6) cells (n = 6), respectively. Trace amounts of LTC4 (0.9 (0.02) ng/10(6) cells, n = 6) were detected in the supernatant of the cells after stimulation by PAF alone (5 microM). The amount of LTC4 released upon stimulation by calcium ionophore A23187 alone in eosinophils from healthy donors was 10.3 (3.7) ng/10(6) cells (n = 4). The amounts of LTC4 released upon stimulation with calcium ionophore A23187 after pretreatment with PAF at concentrations of 1, 5, and 10 microM were 11.9 (3.5), 17.8 (5.6), and 12.7 (5.1) ng/10(6) cells (n = 4), respectively. Trace amounts of LTC4 (0.6 (0.02) ng/10(6) cells, n = 4) were detected in the supernatant of the cells upon stimulation with PAF alone (5 microM). The amounts of LTC4 released upon stimulation with calcium ionophore A23187 after pretreatment with lyso-PAF at concentrations of 1, 5, and 10 microM (n = 4 or 6) were 30.8 (5.2), 22.9 (5.1), and 27.3 (4.3) ng/10(6) cells (n = 6) from the eosinophils of asthmatic patients and 13.7 (3.3), 15.2 (4.9), and 14.7 (3.8) ng/10(6) cells (n = 4) from the eosinophils of healthy donors.
CONCLUSIONS: The results indicated that PAF enhanced LTC4 formation by eosinophils obtained from asthmatic patients stimulated with the calcium ionophore A23187, but not those obtained from normal subjects.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8711647      PMCID: PMC473025          DOI: 10.1136/thx.51.2.155

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  28 in total

1.  Platelet-activating factor induces leukotriene C4 synthesis by purified human eosinophils.

Authors:  P L Bruijnzeel; P T Kok; M L Hamelink; A M Kijne; J Verhagen
Journal:  Prostaglandins       Date:  1987-08

2.  Characterization of platelet-activating factor-induced elevation of cytosolic free calcium concentration in eosinophils.

Authors:  C Kroegel; R Pleass; T Yukawa; K F Chung; J Westwick; P J Barnes
Journal:  FEBS Lett       Date:  1989-01-16       Impact factor: 4.124

3.  Platelet-activating factor (PAF) acts as an intercellular messenger in the changes of cytosolic free Ca2+ in human neutrophils induced by opsonized particles.

Authors:  A T Tool; A J Verhoeven; D Roos; L Koenderman
Journal:  FEBS Lett       Date:  1989-12-18       Impact factor: 4.124

4.  Stimulation of degranulation from human eosinophils by platelet-activating factor.

Authors:  C Kroegel; T Yukawa; G Dent; P Venge; K F Chung; P J Barnes
Journal:  J Immunol       Date:  1989-05-15       Impact factor: 5.422

5.  Enhanced leukotriene C4 production by peripheral eosinophilic granulocytes from children with asthma.

Authors:  U Schauer; A Eckhart; R Müller; D Gemsa; C H Rieger
Journal:  Int Arch Allergy Appl Immunol       Date:  1989

6.  Increased numbers of hypodense eosinophils in the blood of patients with bronchial asthma.

Authors:  T Fukuda; S L Dunnette; C E Reed; S J Ackerman; M S Peters; G J Gleich
Journal:  Am Rev Respir Dis       Date:  1985-11

7.  Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: predominant production of leukotriene C4.

Authors:  P F Weller; C W Lee; D W Foster; E J Corey; K F Austen; R A Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  1983-12       Impact factor: 11.205

8.  Arachidonic acid metabolism in normal and hypereosinophilic syndrome human eosinophils: generation of leukotrienes B4, C4, D4 and 15-lipoxygenase products.

Authors:  W R Henderson; J B Harley; A S Fauci
Journal:  Immunology       Date:  1984-04       Impact factor: 7.397

9.  Platelet-activating factor (PAF-acether) induced leukotriene C4 formation and luminol dependent chemiluminescence by human eosinophils.

Authors:  P L Bruynzeel; L Koenderman; P T Kok; M L Hameling; J Verhagen
Journal:  Pharmacol Res Commun       Date:  1986-08

10.  Platelet-activating factor stimulation of peptidoleukotriene release: inhibition by vasoactive polypeptide.

Authors:  B B Beaubien; J R Tippins; H R Morris
Journal:  Biochem Biophys Res Commun       Date:  1984-11-30       Impact factor: 3.575

View more
  2 in total

1.  Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor.

Authors:  K Shindo; K Koide; M Fukumura
Journal:  Thorax       Date:  1997-12       Impact factor: 9.139

Review 2.  Platelet activating factor as a mediator and therapeutic approach in bronchial asthma.

Authors:  A Kasperska-Zajac; Z Brzoza; B Rogala
Journal:  Inflammation       Date:  2008-01-12       Impact factor: 4.092

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.